33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.61%
Revenue growth under 50% of S's 6.99%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
2.34%
Gross profit growth under 50% of S's 10.07%. Michael Burry would be concerned about a severe competitive disadvantage.
-21.46%
Negative EBIT growth while S is at 0.76%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-21.46%
Negative operating income growth while S is at 0.76%. Joel Greenblatt would press for urgent turnaround measures.
50.35%
Net income growth above 1.5x S's 2.61%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
52.38%
EPS growth above 1.5x S's 4.17%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
52.38%
Diluted EPS growth above 1.5x S's 4.17%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.99%
Share reduction more than 1.5x S's 2.72%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.99%
Diluted share reduction more than 1.5x S's 2.72%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
156.52%
OCF growth under 50% of S's 779.44%. Michael Burry might suspect questionable revenue recognition or rising costs.
142.32%
FCF growth under 50% of S's 414.59%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
35.77%
10Y revenue/share CAGR under 50% of S's 621.35%. Michael Burry would suspect a lasting competitive disadvantage.
35.77%
5Y revenue/share CAGR under 50% of S's 621.35%. Michael Burry would suspect a significant competitive gap or product weakness.
35.77%
3Y revenue/share CAGR under 50% of S's 308.16%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
127.09%
10Y OCF/share CAGR under 50% of S's 347.53%. Michael Burry would worry about a persistent underperformance in cash creation.
127.09%
Below 50% of S's 347.53%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
127.09%
3Y OCF/share CAGR at 50-75% of S's 211.70%. Martin Whitman would suspect weaker recent execution or product competitiveness.
37.87%
Positive 10Y CAGR while S is negative. John Neff might see a substantial advantage in bottom-line trajectory.
37.87%
Positive 5Y CAGR while S is negative. John Neff might view this as a strong mid-term relative advantage.
37.87%
3Y net income/share CAGR above 1.5x S's 8.33%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
-5.83%
Negative equity/share CAGR over 10 years while S stands at 5116.32%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-5.83%
Negative 5Y equity/share growth while S is at 5116.32%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-5.83%
Negative 3Y equity/share growth while S is at 638.18%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-8.06%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
37.20%
We show growth while S is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
0.84%
Positive asset growth while S is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-0.04%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-5.90%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-0.62%
Our R&D shrinks while S invests at 3.32%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
9.02%
SG&A growth well above S's 6.88%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.